All In Biotech

Drug Trial Radar · NCT03030599

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Last checked: Nov 19, 2026Latest source record: Nov 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 201 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

201

Actual

Start

Mar 14, 2017

Primary completion

Jan 24, 2019

Study completion Jul 10, 2019

Sponsor

Lead sponsor
Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
Sponsor type
Industry
First posted
Jan 25, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of JZP-258.

Conditions

  • Narcolepsy With Cataplexy

Interventions

  • JZP-258Drug

    JZP-258 oral solution 0.5 g/mL, which is equivalent to 0.413 g/mL of oxybate

  • PlaceboOther

    Matching placebo solution (aqueous solution containing sodium citrate, malic acid, and sucralose; all ingredients were compendial \[United States Pharmacopeia/ National Formulary\])

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Weekly Number of Cataplexy AttacksTime frame: Change from baseline (2 weeks of the Stable Dose Period) to the 2 weeks of the Double Blind Randomized Withdrawal Period (DB RWP)

Locations

25 sites in 6 countries. Site status is shown where the registry gives one.

  • SDS Clinical Trials, Inc.

    Orange, California

  • Stanford Health Services

    Stanford, California

  • Colorado Sleep Institute

    Boulder, Colorado

  • Pulmonary Disease Specialists

    Kissimmee, Florida

  • Fort Wayne Neurological Center

    Fort Wayne, Indiana

  • Kentucky Research Group

    Louisville, Kentucky

  • Center for Sleep & Wake Disorders

    Chevy Chase, Maryland

  • Montefiore/ Sleep-Wake Disorders Center

    The Bronx, New York

  • Gastonia Medical Specialty Clinic

    Gastonia, North Carolina

  • Research Carolina

    Huntersville, North Carolina

  • Intrepid Research

    Cincinnati, Ohio

  • Cleveland Clinic, Sleep Disorder Center

    Cleveland, Ohio

  • UZ Antwerpen

    Edegem, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • UZ Leuven

    Leuven, Belgium

  • Fakultni nemocnice Ostrava

    Ostrava-Poruba, Czechia

  • Vseobecna fakultni nemocnice v Praze

    Prague, Czechia

  • Helsingin Uniklinikka, Vitalmed Oy

    Helsinki, Finland

  • Hopital Roger Salengro - CHU Lille

    Lille, France

  • Hôpital Gui de Chauliac

    Montpellier, Herault, France

  • Hospital Universitari Vall d'Hebron

    Barcelona, Spain

  • Hospital Clinic i Provincial de Barcelona

    Barcelona, Spain

  • Hospital General de Castellón

    Castelló, Spain

  • Instituto de Investigaciones del Sueño

    Madrid, Spain

  • Hospital Vithas Nuestra Señora de America

    Madrid, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.